Analyzing the Benefits of Using SYMPTOMS-JIT for in Vivo Exposure in Anxiety Disorders

Launched by UNIVERSITAT JAUME I · Jan 16, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a new approach to help people with anxiety disorders, such as specific phobias, panic disorder, agoraphobia, and social anxiety disorder. The study aims to test a smartphone-guided therapy called SYMPTOMS-JIT, which uses technology to provide support when people face anxiety-provoking situations. Researchers want to find out if this method is effective in helping patients manage their anxiety, how well it works over time, and whether patients and therapists prefer it compared to traditional exposure therapy.

To participate in the trial, individuals must be at least 18 years old and diagnosed with one of the specified anxiety disorders. They should be willing to follow the study guidelines and sign a consent form. However, people with other serious psychological issues, substance abuse problems, or those currently receiving similar treatments won't be eligible. Participants can expect to engage in a structured treatment program and will be monitored to see how they respond to the therapy, both immediately and in follow-up assessments over the next year. This study is still in the planning stages and has not started recruiting participants yet.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Being at least 18 years or older.
• • Meeting DSM-5 diagnostic criteria (APA, 2013) for anxiety disorder, specifically specific phobia, agoraphobia, panic disorder and social phobia.
• • Being willing to follow the study conditions.
• • Sign the consent form.
• Exclusion Criteria:
• • Having another psychological problem that requires immediate attention.
• • Having current alcohol or drug dependence or abuse, psychosis or severe organic illness.
• • Currently being treated in a similar treatment program.
• • Taking anxiolytics during the study (or in the case of taking them, changing drug or dose during the study).